X
Search
X

Patient Support Hotline

Call (844) 244-1309

ZERO360 is a free, comprehensive patient support service to help patients and their families navigate insurance and financial obstacles to cover treatment and other critical needs associated with cancer.

X

Subscribe to our E-Newsletter

Stay up-to-date on the latest news about prostate cancer. Join our distribution list to receive periodic email updates and our monthly e-newsletter.

  • Patient Support (844) 244-1309
  • Search
  • e-News Signup Enews Signup
  • Run/Walk
  • Donate

Dr. David Samadi from RoboticOncology voices concerns of COVID-19’s impact on prostate cancer screenings

A concerning fallout from the March COVID-19 shutdown has been the disastrous drop in cancer screenings. This worrisome discovery is according to a study in May by Epic Health Research Network. A review of data from 39 health systems from 190 hospitals in 23 states, found alarming statistics: prostate specific antigen (PSA ) screenings for detecting prostate cancer fell by 60 percent.

Read the full article here.

source: WFMZ TV-69 News